Dr. Zachary S. Zumsteg
Claim this profileCedars Sinai Medical Center
Studies Oropharyngeal Carcinoma
Studies Oropharyngeal Cancer
10 reported clinical trials
28 drugs studied
Area of expertise
1Oropharyngeal Carcinoma
p16 positive
p16 negative
Stage IV
2Oropharyngeal Cancer
p16 positive
p16 negative
high-risk HPV positive
Affiliated Hospitals
Clinical Trials Zachary S. Zumsteg is currently running
Chemotherapy + Radiation Therapy
for Head and Neck Cancer
This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria
Cisplatin
for Oropharyngeal Cancer
This is a single institution phase II study that will enroll patients with T0-3N0-2 p16-positive oropharyngeal squamous cell carcinoma (OSCC) undergoing resection of all gross visible disease at the primary site and in the lymph nodes.
Recruiting1 award Phase 27 criteria
More about Zachary S. Zumsteg
Clinical Trial Related12 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Zachary S. Zumsteg has experience with
- Cisplatin
- Intensity-Modulated Radiation Therapy
- Radiation Therapy
- Degarelix
- Histrelin
- Bicalutamide
Breakdown of trials Zachary S. Zumsteg has run
Oropharyngeal Carcinoma
Oropharyngeal Cancer
Squamous Cell Carcinoma
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Zachary S. Zumsteg specialize in?
Zachary S. Zumsteg focuses on Oropharyngeal Carcinoma and Oropharyngeal Cancer. In particular, much of their work with Oropharyngeal Carcinoma has involved p16 positive patients, or patients who are p16 negative.
Is Zachary S. Zumsteg currently recruiting for clinical trials?
Yes, Zachary S. Zumsteg is currently recruiting for 3 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Zachary S. Zumsteg has studied deeply?
Yes, Zachary S. Zumsteg has studied treatments such as Cisplatin, Intensity-Modulated Radiation Therapy, Radiation Therapy.
What is the best way to schedule an appointment with Zachary S. Zumsteg?
Apply for one of the trials that Zachary S. Zumsteg is conducting.
What is the office address of Zachary S. Zumsteg?
The office of Zachary S. Zumsteg is located at: Cedars Sinai Medical Center, Los Angeles, California 90048 United States. This is the address for their practice at the Cedars Sinai Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.